Revenue - Schedule of Revenue Disaggregated by Customer Type (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Disaggregation of Revenue [Line Items]
Revenue	[1]	$ 14,495	$ 25,709	$ 52,303	$ 67,814
Pharma Tests and Services
Disaggregation of Revenue [Line Items]
Revenue	[2]	13,137	15,698	37,754	38,707
Enterprise Sales
Disaggregation of Revenue [Line Items]
Revenue		650	5,264	5,430	21,194
Population Sequencing
Disaggregation of Revenue [Line Items]
Revenue		234	4,431	7,755	7,211
Clinical diagnostic
Disaggregation of Revenue [Line Items]
Revenue		384	271	1,161	583
Other
Disaggregation of Revenue [Line Items]
Revenue		$ 90	$ 45	$ 203	$ 119

[1] Includes related party revenue of $1.1 million and $3.5 million for the three and nine months ended September 30, 2025, respectively.

[2] Includes related party revenue of $1.1 million and $3.5 million for the three and nine months ended September 30, 2025,respectively.